Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 52(10): 6079-6091, 2024 Jun 10.
Article in English | MEDLINE | ID: mdl-38661215

ABSTRACT

CRISPR-Cas systems can be utilized as programmable-spectrum antimicrobials to combat bacterial infections. However, how CRISPR nucleases perform as antimicrobials across target sites and strains remains poorly explored. Here, we address this knowledge gap by systematically interrogating the use of CRISPR antimicrobials using multidrug-resistant and hypervirulent strains of Klebsiella pneumoniae as models. Comparing different Cas nucleases, DNA-targeting nucleases outperformed RNA-targeting nucleases based on the tested targets. Focusing on AsCas12a that exhibited robust targeting across different strains, we found that the elucidated modes of escape varied widely, restraining opportunities to enhance killing. We also encountered individual guide RNAs yielding different extents of clearance across strains, which were linked to an interplay between improper gRNA folding and strain-specific DNA repair and survival. To explore features that could improve targeting across strains, we performed a genome-wide screen in different K. pneumoniae strains that yielded guide design rules and trained an algorithm for predicting guide efficiency. Finally, we showed that Cas12a antimicrobials can be exploited to eliminate K. pneumoniae when encoded in phagemids delivered by T7-like phages. Altogether, our results highlight the importance of evaluating antimicrobial activity of CRISPR antimicrobials across relevant strains and define critical parameters for efficient CRISPR-based targeting.


Subject(s)
CRISPR-Cas Systems , Klebsiella pneumoniae , RNA, Guide, CRISPR-Cas Systems , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/drug effects , RNA, Guide, CRISPR-Cas Systems/genetics , RNA, Guide, CRISPR-Cas Systems/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Endodeoxyribonucleases/metabolism , Endodeoxyribonucleases/genetics , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , CRISPR-Associated Proteins/metabolism , CRISPR-Associated Proteins/genetics , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Clustered Regularly Interspaced Short Palindromic Repeats , Genome, Bacterial/genetics , Gene Editing/methods , Humans
2.
Methods Mol Biol ; 2793: 85-100, 2024.
Article in English | MEDLINE | ID: mdl-38526725

ABSTRACT

Bacteriophage T7 is an intracellular virus that recognizes its host via tail and tail fiber proteins known as receptor-binding proteins (RBPs). The RBPs attach to a specific lipopolysaccharide (LPS) displayed on the host. While there are various reports of phage host range expansion resulting from mutations in the RBP encoding genes, there is little evidence for contraction of host range. Notably, most experimental systems have not monitored changes in host range in the presence of several hosts simultaneously. Here, we use a continuous evolution system to show that T7 phages grown in the presence of five restrictive strains and one permissive host, each with a different LPS, gradually cease to recognize the restrictive strains. Remarkably, this result was obtained in experiments with six different permissive hosts. The altered specificity is due to mutations in the RBPs as determined by gene sequencing. The results of using this system demonstrate a major role for RBPs in restricting the range of futile infections, and this process can be harnessed to reduce the host range in applications such as recognition and elimination of a specific bacterial serotype by bacteriophages.


Subject(s)
Bacteriophage T7 , Bacteriophages , Bacteriophage T7/genetics , Lipopolysaccharides/metabolism , Bacteriophages/genetics , Protein Binding , Carrier Proteins/metabolism , Host Specificity
SELECTION OF CITATIONS
SEARCH DETAIL